HPB & Spleen · 9 January 2024

Impaired liver function after major hepatectomy affects feasibility of adjuvant chemotherapy for biliary tract cancers

The study explored the feasibility of S-1 adjuvant chemotherapy after major hepatectomy for biliary tract cancers. Comparing major hepatectomy (mh) with non-major hepatectomy (nmh), researchers found that mh had a lower treatment completion proportion and dose intensity. Additionally, caution should be exercised to prevent biliary tract infections and gastrointestinal disorders during adjuvant S-1 chemotherapy after mh for biliary tract cancers.

Journal Article by Kobayashi S, Nakachi K (…) Furuse J et 17 al. in Eur J Surg Oncol

read the whole article in Eur J Surg Oncol

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in HPB & Spleen.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

The latest stitches

BMC Surg5 Nov 2026

Weight did not predict robotic liver surgery outcomes

Obese patients recovered as smoothly as normal-weight patients after robotic liver resection at experienced centers, according to a multinational study across 29 centers.

BMC Surg5 Nov 2026

Body mass index did not independently predict outcomes after robotic liver resection

Obesity alone did not predict worse results after robotic liver surgery at experienced centers.

Ann Surg Oncol3 Nov 2026

Nutrition and immune blood markers predict survival in gallbladder cancer

Patients with better blood nutrition scores lived longer after surgery for gallbladder cancer, in a study of 1,312 patients.

All papers in HPB & Spleen →